NASDAQ:MLAB

Mesa Laboratories Stock Forecast, Price & News

$294.51
+2.73 (+0.94 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$291.91
$294.89
50-Day Range
$245.80
$294.51
52-Week Range
$229.00
$307.97
Volume14,430 shs
Average Volume13,895 shs
Market Capitalization$1.53 billion
P/E Ratio507.78
Dividend Yield0.22%
Beta0.38
30 days | 90 days | 365 days | Advanced Chart
Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.


Mesa Laboratories logo

About Mesa Laboratories

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.19 out of 5 stars

Analyst Opinion: 1.0Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

Is Mesa Laboratories a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Mesa Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MLAB, but not buy additional shares or sell existing shares.
View analyst ratings for Mesa Laboratories
or view top-rated stocks.

What stocks does MarketBeat like better than Mesa Laboratories?

Wall Street analysts have given Mesa Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mesa Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Mesa Laboratories
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its quarterly earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to analysts' expectations of $34.92 million. Mesa Laboratories had a net margin of 2.30% and a trailing twelve-month return on equity of 6.65%.
View Mesa Laboratories' earnings history
.

How has Mesa Laboratories' stock been impacted by COVID-19?

Mesa Laboratories' stock was trading at $230.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MLAB shares have increased by 27.5% and is now trading at $294.51.
View which stocks have been most impacted by COVID-19
.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, July 6th. Shareholders of record on Tuesday, August 31st will be given a dividend of $0.16 per share on Wednesday, September 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.22%. The ex-dividend date is Monday, August 30th.
View Mesa Laboratories' dividend history
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.22%. Mesa Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Mesa Laboratories is 12.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 13.28% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.
View Mesa Laboratories' dividend history.

What price target have analysts set for MLAB?

2 Wall Street analysts have issued 12-month price objectives for Mesa Laboratories' shares. Their forecasts range from $260.00 to $287.00. On average, they expect Mesa Laboratories' share price to reach $273.50 in the next twelve months. This suggests that the stock has a possible downside of 7.1%.
View analysts' price targets for Mesa Laboratories
or view top-rated stocks among Wall Street analysts.

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the following people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 53, Pay $1.19M)
  • Mr. John V. Sakys, CFO, Chief Accounting Officer & Treasurer (Age 52, Pay $596.4k)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 56, Pay $491.16k)
  • Mr. Brian David Archbold, Sr. VP of Continuous Improvement (Age 56, Pay $423.68k)
  • Mr. Robert Bradley, Sr. Director of Operations
  • Ms. Elizabeth Karpinski Vonne, VP of Legal, Gen. Counsel & Sec.
  • Ms. Gina Hinman Trulli, VP of HR
  • Mr. Bryan T. Leo, Sr. VP of Operations
  • Mr. Garrett Krushefski, Sr. VP of Operations

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories CEO Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among Mesa Laboratories' employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (9.78%), Alliancebernstein L.P. (0.28%), Rice Hall James & Associates LLC (0.14%), Exchange Traded Concepts LLC (0.07%), State of Alaska Department of Revenue (0.07%) and Huntington National Bank (0.01%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Robert V Dwyer.
View institutional ownership trends for Mesa Laboratories
.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, and Rice Hall James & Associates LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, and John Sakys.
View insider buying and selling activity for Mesa Laboratories
or view top insider-selling stocks.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Exchange Traded Concepts LLC, Huntington National Bank, and State of Alaska Department of Revenue.
View insider buying and selling activity for Mesa Laboratories
or or view top insider-buying stocks.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $294.51.

How much money does Mesa Laboratories make?

Mesa Laboratories has a market capitalization of $1.53 billion and generates $133.94 million in revenue each year. The medical instruments supplier earns $3.27 million in net income (profit) each year or $5.24 on an earnings per share basis.

How many employees does Mesa Laboratories have?

Mesa Laboratories employs 506 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

Where are Mesa Laboratories' headquarters?

Mesa Laboratories is headquartered at 12100 W 6TH AVE, LAKEWOOD CO, 80228.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.